30: Growing Early Biotech Startups Through Connection – Dan Bloomfield

The Emerging Biotech Leader
The Emerging Biotech Leader
30: Growing Early Biotech Startups Through Connection - Dan Bloomfield
Loading
/

In this episode of the Emerging Biotech Leader podcast, hosts Kim Kushner and Ramin Farhad speak with Dr. Dan Bloomfield, Chief Medical Officer of Anthos Therapeutics. Dan generously shares insights from his diverse career that has spanned academia at Columbia University, over a decade at big pharma giant Merck across multiple leadership roles, and most … Read more

EP. 29: Lessons In Biotechs with Bold Missions ft. Bob Honigberg

The Emerging Biotech Leader Podcast
The Emerging Biotech Leader Podcast
EP. 29: Lessons In Biotechs with Bold Missions ft. Bob Honigberg
Loading
/

In this episode of the Emerging Biotech Leader podcast, hosts Kim Kushner and Ramin Farhood are joined by Bob Honigberg to further discuss the considerable challenge of achieving bold missions in healthcare. Building on their discussion from Episode 28 where they interviewed Cleerly Health founder Dr. Jim Ninh, the episode provides useful perspectives for any … Read more

Ep. 28: Lessons In Clinical Trials With The Unlikely Entrepreneur – Ft. Jim Min

The Emerging Biotech Leader Podcast
The Emerging Biotech Leader Podcast
Ep. 28: Lessons In Clinical Trials With The Unlikely Entrepreneur - Ft. Jim Min
Loading
/

“I believe that we can eradicate heart attacks from this world…If we can leverage these tools to accomplish those three goals, whether it’s in coronary heart disease, valvular heart disease, myocardial disease, et cetera, et cetera, I think that’s going to not be a slight improvement. I think it’s going to be a game changer … Read more

Ep. 27: Building A Biotech ft. Adriana Valenciano

The Emerging Biotech Leader Podcast
The Emerging Biotech Leader Podcast
Ep. 27: Building A Biotech ft. Adriana Valenciano
Loading
/

“I think outcomes for a lot of people means meeting milestones. So hitting that next clinical milestone, CMC milestone, et cetera, and that’s, I think, one way of looking at it. Still, it’s also about the culmination of outcomes and achieving something greater than bringing together one discipline and one win.” ~ Adriana Valenciano, SVP, … Read more

Ep. 26: Recalibrating Early Stages of Corporate Build – Johan Strömquist

The Emerging Biotech Leader Podcast
The Emerging Biotech Leader Podcast
Ep. 26: Recalibrating Early Stages of Corporate Build - Johan Strömquist
Loading
/

“Getting a drug to market is a change journey. The whole process is a change journey. And we pass through so many different stages and gates on the way there: we need to adapt almost regardless of circumstances, even if everything goes according to plan, we have to shift.” Johan Stromquist, President, NDA Group As … Read more